-
EZ Cap™ Cre mRNA (m1Ψ): Assay Design
2026-09-03
Learn how EZ Cap™ Cre mRNA (m1Ψ) can serve as a mechanistically resolved assay payload for evaluating mRNA delivery, translation, nuclear access, and loxP recombination. This guide connects Cre biology with emerging extrahepatic delivery platforms while defining practical controls and handling considerations.
-
PTT and CD47 Blockade in Oral Squamous Cell Carcinoma
2026-09-02
A 2026 study shows that photothermal therapy (PTT) can strengthen CD47 blockade in oral squamous cell carcinoma by generating a calreticulin-dependent “eat me” signal and improving macrophage access through extracellular matrix remodeling. The findings support a dual-barrier strategy for solid-tumor immunotherapy, while also clarifying which experimental readouts are needed to distinguish immune activation from nonspecific thermal injury.
-
Mitochondrial Potential as a Translational Immune Readout
2026-09-02
Mitochondrial membrane potential can convert mechanistic hypotheses about redox stress and immunogenic tumor cell death into a measurable translational endpoint. This thought-leadership guide shows how to position JC-1 ratiometric analysis alongside TrxR/MAPK biology, apoptosis assays, and immune phenotyping without overinterpreting depolarization as proof of clinical efficacy.
-
GSDMC Rewires PDAC Stemness and Immune Evasion
2026-09-01
A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a nuclear regulator of pancreatic ductal adenocarcinoma rather than solely a pyroptosis-associated pore-forming protein. The work links ADAM17-dependent GSDMC cleavage to stemness, metastasis, CXCL9-controlled immune exclusion, and improved responses to KRASG12D inhibition and PD-1 blockade in preclinical models.
-
Toremifene for Breast Cancer: 20 Years of Evidence
2026-08-31
This review synthesizes two decades of clinical and pharmacologic evidence for toremifene, an oral selective estrogen receptor modulator, in postmenopausal estrogen receptor-positive breast cancer. Its main contribution is a balanced interpretation of efficacy, safety, tissue-selective activity, and pharmacokinetic differences from tamoxifen, helping researchers and clinicians place toremifene within individualized endocrine therapy.
-
Nelfinavir Mesylate: From HIV to Ferroptosis
2026-08-31
Nelfinavir Mesylate is an HIV-1 protease inhibitor with a well-defined antiviral mechanism and emerging value in ferroptosis research. This article explains how to separate validated HIV pharmacology from exploratory DDI2–NFE2L1 assay interpretation.
-
Mitomycin C as an ICL-Repair Assay Probe
2026-08-30
Mitomycin C is more than a cytotoxic DNA synthesis inhibitor: it can serve as a strategic probe of interstrand crosslink repair. This article connects its assay use to ERCC1 and p53 biology, clarifying controls, readouts, and interpretation limits for cancer research.
-
Cy3-UTP Workflows for Fluorescent RNA Assays
2026-08-29
Cy3-UTP enables sequence-defined fluorescent RNA for spatial imaging, condensate reconstitution, and RNA-protein interaction studies. This guide connects practical in vitro transcription RNA labeling with assays inspired by replication-organelle clustering and provides optimization steps for signal, RNA function, and reproducibility.
-
Cabazitaxel (XRP6258): Practical Lab Guide
2026-08-29
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble semi-synthetic taxane derivative for studying antiproliferative responses and microtubule dynamics disruption, including workflows involving P-glycoprotein-expressing or taxane-resistant cancer cells. It should be handled in DMSO or ethanol, used promptly after solution preparation, and excluded from water-based assays unless a separately validated formulation is available.
-
Amphotericin B: From Membrane Pores to Translation
2026-08-28
A mechanism-driven framework for using Amphotericin B in fungal infection research, immune-signaling assays, translational model design, and reproducible workflow development.
-
5-Aminolevulinic acid HCl and Heme-Driven Virulence
2026-08-28
Recent Salmonella research reveals that regulated haem biosynthesis can shape macrophage phagocytosis and pathogen fitness. This thought-leadership analysis positions 5-Aminolevulinic acid HCl as a strategic pathway-perturbation reagent for testing precursor rescue, metabolic plasticity, and translational links between infection biology and porphyrin-based cancer research.
-
Chuanxiong Cortex, Pith, and Fenipentol in CHD
2026-08-27
The reference study combines SPME-GC×GC-MS with network pharmacology and molecular docking to distinguish the volatile chemistry and predicted coronary heart disease relevance of Chuanxiong rhizome cortex and pith. Its main contribution is a tissue-resolved framework that places Fenipentol among the prominent cortex-associated constituents while separating analytical identification from mechanistic validation.
-
MLKL Polymerization and Lysosomal Permeabilization
2026-08-27
The reference study identifies lysosomal membrane permeabilization as a critical execution step in necroptosis driven by polymerized MLKL. Through live-cell imaging and CTSB perturbation, it shows that MLKL-dependent lysosomal damage releases cathepsin B before plasma membrane rupture, thereby linking necrosome activation to proteolytic loss of cell survival machinery.
-
NVP-BGJ398 phosphate in Viability Assays
2026-08-26
Learn how NVP-BGJ398 phosphate, SKU A3673, can improve the design and interpretation of FGFR-dependent cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers mechanism, dose selection, formulation, cross-domain applications, and practical vendor-selection criteria.
-
Proteinase K: From DNA Cleanup to Protease Strategy
2026-08-26
Proteinase K is more than a routine digestion reagent: its broad substrate tolerance, nuclease-removal utility, and performance across DNA isolation conditions make it a strategic tool for translational workflow design and protease assay control.
453 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page